🚨The Arabification of North Texas
The Infrastructure Playbook Moves to Dallas–Fort Worth
Arabic-language influencers are openly marketing Dallas–Fort Worth to Arab and Iraqi families as a ready-made destination.
This isn’t random migration. This is infrastructure-first settlement.
The strategy they describe is straightforward:
🔺Follow existing Arab communities
🔺Settle near Islamic schools, mosques, and markets
🔺Expand north into high-growth suburbs
🔺Lock in schools and housing for a long-term presence
In Their Own Words (DFW)
“Dallas Fort Worth is the best place to start your life and your family.”
“There are private Islamic and Arabic schools… Arab restaurants, cafes, markets, mosques - everything is available.”
“Many Arabs moved here from New York, California, and Illinois. Arlington and Richardson are full of Arabs. Now they’re moving north - Plano, Allen, McKinney, Frisco, Prosper, Celina, Melissa.”
“People choose areas based on schools.”
Texas’s new Education Savings Account program is expected to make private Islamic schools eligible for public funding, accelerating the model. Now Texas will be attracting Muslims from blue states all across America!
This is collective relocation with institutional anchors. Mosques comes first, Schools come next, and businesses follow. Political leverage comes later - but it always comes.
The same pattern repeats nationwide: concentration before representation, infrastructure before power, school districts before city councils.
DFW is being sold as a self-contained ecosystem where newcomers don’t have to assimilate because the parallel structure already exists.
Texas is no longer just attracting people. It is being positioned as Arab territory.
This is a coordinated roadmap for demographic consolidation.
🚨🚨 ¿Recuerdas cuando los medios se rieron y te dijeron que la Ivermectina era solo para caballos y vacas? Sabían que estaba hecha para humanos desde 1987...
Esto es lo no querían que supieras...
1 – Previene el daño causado por medicamentos creados con tecnología de ARNm, bloquea la entrada de la Proteína Spike a las células y, si la persona fue vacunada, puede tratarse los daños ya producidos a través de la Ivermectina.
2 – Solo tiene efectos beneficiosos y ningún efecto perjudicial en el tratamiento del virus C. De hecho, incluso antes de entrar en la célula, ya ha destruido el virus en la sangre.
3 – Tiene una acción antiinflamatoria muy potente y tiene un potente impacto sobre lesiones traumáticas y ortopédicas, fortalece los músculos y no tiene efectos secundarios como los corticosteroides.
4 –Trata enfermedades autoinmunes como: artritis reumatoide, espondilitis anquilosante, fibromialgia, psoriasis, enfermedad de Crohn, rinitis alérgica.
5 – Mejora los niveles de inmunidad en pacientes con cáncer y trata el Herpes Simple y el Herpes Zoster, además reduce la frecuencia de sinusitis y diverticulitis.
6 – Protege el corazón en caso de sobrecarga cardíaca. En una embolia, por ejemplo, previene la hipoxia cardíaca, ya que estimula la producción de energía básica para evitar la destrucción del tejido y, por lo tanto, mejora la función cardíaca.
7 – Es antiparasitario y antineoplásico (anticancerígeno). Supuestamente, suprime la proliferación y la metástasis de las células cancerosas, preservando las células sanas y mejorando la eficacia del tratamiento de quimioterapia.
8 - Puede matar células cancerosas resistentes a la quimioterapia, venciendo la resistencia a múltiples quimioterapéuticos que desarrollan los tumores, y combinado con quimioterapia y/o agentes anticancerígenos, proporciona un aumento en la efectividad de estos tratamientos.
9 – Es antimicrobiano (bacterias y virus) y aumenta la inmunidad.
10 – Llega al Sistema Nervioso Central y regenera los nervios.
11 – Ayuda a regular la glucosa, el metabolismo de la insulina, los niveles de colesterol y reduce la grasa hepática en esteatosa.
12 - Puede utilizarse como agente profiláctico y se ha asociado con una reducción significativa en las tasas de infección, hospitalización y mortalidad por C-19.
🚨🚨 La historia no contada de un «fármaco milagroso»...
• Descubierto en un campo de golf en Japón
• Ha llevado la ceguera de los ríos al borde de la eliminación.
• Ganó el premio Nobel en 2015
• Reconocida, después de la penicilina, por tener el mayor impacto en la salud humana.
• Más de 3.700 millones de dosis...
• Este asesino de parásitos ahora convertido también en terror de tumores...
12 Acciones Anticáncer Conocidas:
1. Inhibe la vía WNT/β-catenina: detiene la proliferación de células cancerosas.
2. Induce la apoptosis: desencadena la muerte programada de las células cancerosas.
3. Bloquea las proteínas transportadoras de importina α/β, lo que impide la replicación de células cancerosas.
4. Inhibe la enzima PAK1: reduce la inflamación y la progresión tumoral.
5. Antiangiogénico: detiene la formación de nuevos vasos sanguíneos en los tumores.
6. Modulador del sistema inmunológico: mejora el reconocimiento de las células cancerosas.
7. Disruptor de la autofagia: interfiere con las estrategias de supervivencia de las células cancerosas.
8. Se dirige a las células madre del glioblastoma: eficaz en cánceres cerebrales.
9. Inhibe la respiración mitocondrial: corta el suministro de energía a los tumores.
10. Interrumpe la señalización de mTOR, lo que ralentiza el crecimiento celular.
11. Supera la resistencia a la quimioterapia: hace que la quimioterapia sea más efectiva.
12. Propiedades antivirales: potencialmente útiles para cánceres relacionados con virus (como el VPH).
An 80-year-old Japanese-American woman with advanced Alzheimer’s—bedbound, incontinent, and speaking only in single syllables for years—just shattered our understanding of neurodegeneration.
After a single supervised 5-gram dose of psilocybin mushrooms (Enigma strain), she woke up after 19 hours and did the impossible:
+ Regained full speech (forming complete, coherent sentences)
+ Recovered lost memories (recalling long-forgotten life events)
+ Regained mobility & continence (dressing herself and staying dry)
+ Restored eye contact and humor
A follow-up 3-gram dose one month later boosted her verbal fluency and agility even further. These gains lasted for weeks.
🧠 This Is Not A Cure. It’s Something More Profound.
The case report, published in Frontiers in Neuroscience (May 27, 2026), proves that functions we assumed were irreversibly destroyed by dementia are actually still there—they are simply trapped behind broken neural gates. Psilocybin bypassed the damage. How? Through explosive, rapid neuroplasticity:
+ The 5-HT2A Switch: Psilocybin floods 5-HT2A serotonin receptors, triggering a massive spike in BDNF (Brain-Derived Neurotrophic Factor).
+ Neural Rewiring: BDNF acts like fertilizer for the brain, driving dendritic spine growth, synaptogenesis, and the repair of broken networks.
+ Circuit Restoration: It downregulates chronic neuroinflammation and re-establishes critical communication between the hippocampus and prefrontal cortex.
🛑 The Tragedy of Our Delay: Johns Hopkins is already studying psilocybin for depression in early-stage cognitive decline. But for late-stage, severe patients? It is an absolute shame that we aren't taking these trials more seriously. Modern medicine has exactly zero treatments that restore lost function in advanced dementia. This single case demands immediate action.
We don't have time to wait for a 10-year bureaucratic pipeline while millions of minds fade into the fog.
⚡ The Directive for Compassionate Use: President Trump’s executive order accelerating psychedelic research gives us the exact legal framework we need. We must bypass the standard red tape and establish compassionate use protocols immediately for advanced patients. For millions of families watching their loved ones slip away, this case report is a thunderbolt of hope. The brain still holds secrets, and science moves fast when we get out of its way.
What if a single guided experience could give you back one last conversation with the person you love?
🔄 Share this if you want real hope for dementia. Access and research must accelerate NOW.
#Psilocybin #Alzheimers #Neuroplasticity #BDNF #MedicalBreakthrough #CompassionateUse #Dementia
BREAKING: Largest Human Cancer Study of Ivermectin + Mebendazole Is Now PEER-REVIEWED and PUBLISHED in a MAJOR Cancer Journal
84.4% of cancer patients taking ivermectin + mebendazole for 6 months declared either CANCER DISAPPEARANCE, TUMOR REGRESSION, or CANCER STABILIZATION.
Our study, “Real-world Clinical Outcomes of Ivermectin and Mebendazole in Cancer Patients: Results from a Prospective Observational Cohort,” is now peer-reviewed and published in Anticancer Research—a major international oncology journal of the International Institute of Anticancer Research (IIAR), established in 1995.
The results represent one of the most compelling clinical signals ever documented for repurposed anti-parasitic therapies in oncology.
A diverse population of cancer patients (n=197) was prescribed compounded ivermectin–mebendazole through a U.S. telemedicine platform, with each capsule containing 25 mg ivermectin and 250 mg mebendazole.
Participants were followed for approximately six months using standardized digital surveys assessing cancer outcomes, medication adherence, and tolerability.
At approximately six months post-treatment initiation, we observed an 84.4% Clinical Benefit Ratio (CBR)—meaning more than four out of five patients reported either:
No evidence of disease (32.8%)
Tumor regression (15.6%)
or Cancer stabilization (36.1%)
Importantly, adherence was remarkably high, with 86.9% completing the initial prescription and 66.4% remaining on therapy at six months.
Side effects were predominantly mild and manageable, reported in 25.4% of patients (primarily gastrointestinal), with 93.6% of those experiencing side effects continuing treatment after minor dosing adjustments.
This groundbreaking peer-reviewed publication was made possible through a unique collaboration between The Wellness Company, the McCullough Foundation, and the Chairman of the President’s Cancer Panel—uniting real-world clinical data, frontline medical experience, and epidemiologic expertise to evaluate inexpensive, repurposed therapies with major translational potential.
With these extraordinarily promising results, double-blind, placebo-controlled clinical trials are now required.
In the meantime, many cancer patients are exercising their right to try.
@twc_health@McCulloughFund@IIAR_Journals@P_McCulloughMD@DrHarveyRisch@DrKellyVictory@jathorpmfm@drdrew@PeterGillooly@FosterCoulson
IVERMECTIN: FULL DOSAGE SCHEDULE FOR CANCER & PREVENTION
1000s of people use Dr. William Makis MD’s IVERMECTIN dosing chart. Here’s a clear, categorized breakdown based on body weight (mg/kg per day).
LOW DOSE: ≤ 0.5 mg/kg/day
**Best for:**
- Cancers in remission
- Strong family history or genetic predisposition
- Prophylaxis (preventive)
**Side effects:** No long-term side effects reported.
**Example:** Dr. Tess Lawrie reported a Stage 3 ovarian cancer case treated with chemo + 12 mg ivermectin daily. Tumor marker CA125 dropped from 288 to 22 after 2 months and the tumor vanished.
MEDIUM DOSE: 1.0 mg/kg/day
**Best for:** Starting dose for **most cancers** (lung, pancreatic, renal cell, gastric, etc.).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Shankara Chetty’s 70-year-old prostate cancer patient (PSA 89) took 45 mg/day (plus lactoferrin). After two months PSA fell to 10.9.
HIGH DOSE: 2.0 mg/kg/day
**Best for:** Very aggressive cancers (leukemia, pancreatic, brain cancers).
**Side effects:** No long-term side effects reported.
**Example:** Dr. Allan Landrito’s Stage 4 gallbladder cancer patient took 2 mg/kg daily for 14 months — cancer disappeared.
VERY HIGH DOSE: ≥ 2.5 mg/kg/day
**Best for:** Extensive metastatic disease, extremely poor prognosis, or certain brain cancers.
**Side effects:** Possible short-term & transient visual effects (usually resolve in a few days).
**Example:** Dr. Shankara Chetty treated a patient with 2.5 mg/kg/day — no side effects reported.
**Quick conversion example (for a 60 kg / 132 lb person):**
- Low: ≤30 mg/day
- Medium: 60 mg/day (≈5×12 mg tablets or 1 teaspoon liquid)
- High: 120 mg/day
- Very High: ≥150 mg/day
Many anecdotal reports exist of long-term daily use (months to over a year) with no serious toxicity, but individual responses vary.
Always work with a knowledgeable clinician, especially if you have pre-existing conditions (e.g., vision issues or glaucoma). This is for educational purposes only.
Share to spread awareness — information is power. 💊 Kindly follow me for daily updates. Thank you.
Hastanede bekleyen hastalara uzaktan bakan doktor, bir adamın baygın olduğunu fark ediyor.
Eliyle yaptığı ufak bir kontrol sonrası nabız alamayan doktor, anında CPR’a (Kalp Masajı) başlarken Mavi KoD(Kalp durma kodu) veriyor.
Hemşirelerin yardımıyla hasta, müdahale hiç kesilmeden yoğun bakıma kaldırılıyor ve hastanın hayatı, doktorun inanılmaz çabaları sayesinde mucizevi bir şekilde kurtuluyor!